Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00945243 · ClinicalTrials.gov registry record · NA
Clinical Outcomes Study Evaluating the Zero-P PEEK
A NA study, sponsored by Synthes USA HQ.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00945243: Clinical Trial NA study, sponsored by Synthes USA HQ.
NCT00945243 is a NA study that was terminated before completion, run by Synthes USA HQ. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00945243, a NA study, was terminated before completion, sponsored by Synthes USA HQ.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This is a multi-center, prospective, outcomes study. In this study, the Zero-P PEEK implant will be used in patients undergoing ACDF for treatment of SCDD at a single level between C3 and C7. The cohort will be followed over time to twenty-four (24) months after surgery. Up to fifteen (15) sites will participate in this study. This is not a controlled study.
Primary Outcome
Percentage of subjects who experienced a maintenance or improvement according to measures of pain and/or function.
Interventions
- DEVICE Zero-P
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-07-01 |
| Est. Completion | 2011-12-01 |
| Phase | NA |
Why NCT00945243 stopped before completion
NCT00945243 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Zero-P is the first listed.
NCT00945243 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00945243 about?
NCT00945243 is a clinical study titled "Clinical Outcomes Study Evaluating the Zero-P PEEK". This is a multi-center, prospective, outcomes study. In this study, the Zero-P PEEK implant will be used in patients undergoing ACDF for treatment of SCDD at a single level between C3 and C7. The cohort will be followed over time to twenty-four (24) months after surgery. Up to fifteen (15) sites wil...
What is the current status of trial NCT00945243?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2009-07-01. Estimated completion is 2011-12-01.
What interventions are being tested in trial NCT00945243?
The interventions under investigation include: Zero-P (DEVICE).
Who is sponsoring clinical trial NCT00945243?
This trial is sponsored by Synthes USA HQ, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00945243's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI